Evidence map›Paper›PMID 29849864›Full record

ArticleOxidative medicine and cellular longevity2018

Julio Benites, Héctor Toledo, Felipe Salas, Angélica Guerrero, David Rios, Jaime A Valderrama, Pedro Buc Calderon

Open access · hybridAbstract read
In one paragraph

Article in Oxidative medicine and cellular longevity, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.8field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. International journal of microbiology · 2022
    Article
  5. Identification of Potential Drug Targets inPathogens (Basel, Switzerland) · 2020
    Article
  6. Article
  7. New 2-Acetyl-3-aminophenyl-1,4-naphthoquinones: Synthesis andOxidative medicine and cellular longevity · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Julio BenitesFacultad de Ciencias de la Salud, Universidad Arturo Prat, Casilla 121, 1100000 Iquique, Chile.ORCID 0000-0002-8562-0078
Héctor ToledoInstituto de Ciencias Biomédicas (ICBM), Facultad de Medicina, Universidad de Chile, 8380453 Santiago, Chile.ORCID 0000-0001-8813-2873
Felipe SalasFacultad de Ciencias de la Salud, Universidad Arturo Prat, Casilla 121, 1100000 Iquique, Chile.
Angélica GuerreroFacultad de Ciencias de la Salud, Universidad Arturo Prat, Casilla 121, 1100000 Iquique, Chile.
David RiosFacultad de Ciencias de la Salud, Universidad Arturo Prat, Casilla 121, 1100000 Iquique, Chile.
Jaime A ValderramaInstituto de Ciencias Exactas y Naturales, Universidad Arturo Prat, Casilla 121, 1100000 Iquique, Chile.
Pedro Buc CalderonFacultad de Ciencias de la Salud, Universidad Arturo Prat, Casilla 121, 1100000 Iquique, Chile.ORCID 0000-0003-0483-2624
Arturo Prat University · CLUniversity of Chile · CL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Infection by

Indexed as

Anti-Bacterial AgentsBiological ProductsHelicobacter InfectionsHelicobacter pyloriHumansNaphthoquinonesOxidation-ReductionAnti-Bacterial AgentsBiological ProductsjugloneNaphthoquinones

Identifiers

PMID29849864
PMCPMC5941820
OpenAlexW2801573016

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.